90 results
Page 3 of 5
S-3ASR
yogrwue0d3kglv
10 Aug 20
Automatic shelf registration
5:01pm
424B5
81ggpmtggezress
2 Jun 20
Prospectus supplement for primary offering
5:05pm
424B5
bzbgc
1 Jun 20
Prospectus supplement for primary offering
6:06am
8-K
EX-10.1
6a6t 1iy4yohqvn
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
424B5
f5t7x0
22 Jan 20
Prospectus supplement for primary offering
5:31pm
424B5
k6ata ri6
21 Jan 20
Prospectus supplement for primary offering
5:21pm
8-K
EX-99.1
zbryn7v p36rob2
6 Nov 19
Adaptimmune Reports Third Quarter 2019 Financial Results and Business Update
7:35am
8-K
EX-99.1
eah97 gkeq
1 Aug 19
Adaptimmune Reports Second Quarter 2019 Financial Results and Business Update
7:23am
8-K
EX-99.1
s8lx1sfyxhxhhr 54cvv
18 Jul 19
Adaptimmune Starts the SURPASS Clinical Trial with its first Next-Generation SPEAR T-cells Targeting MAGE-A4 to Enhance Antitumor Responses
8:11am
8-K
EX-10.4
9hcl9pmvt7m 3epipe
27 Jun 19
Departure of Directors or Certain Officers
8:08am